U.S. federal trademark · Serial No. 86880860 · Reg. No. 5897433
Biologics, namely, chimeric immune cell antigen receptors, namely, engineered immune cells made from an individual patient's immune cells and proprietary DNA, for therapeutic use for the treatment of cancers, for the treatment of proliferative cell diseases [ , and in transplantation ]
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.